Bacterial Pneumonia Multiplex Bordetella Legionella Klebsiella Detection Differentiation RNA Detection Qualitative Test
Comprehensive Respiratory Pathogen Detection
The Bacterial Pneumonia Multiplex RNA Detection Qualitative Test represents a significant advancement in respiratory infection diagnostics. This sophisticated molecular test utilizes cutting-edge Real Time PCR technology to simultaneously detect and differentiate three critical bacterial pathogens that commonly cause severe pneumonia and respiratory complications. By providing rapid, accurate identification of Bordetella pertussis, Legionella pneumophila, and Klebsiella pneumoniae, this test enables healthcare providers to implement targeted treatment strategies quickly, potentially saving lives and reducing the spread of infectious diseases.
What This Test Detects
This multiplex test specifically identifies RNA from three major bacterial pathogens:
- Bordetella pertussis: The causative agent of whooping cough, known for severe paroxysmal coughing
- Legionella pneumophila: Responsible for Legionnaires’ disease, a severe form of pneumonia
- Klebsiella pneumoniae: A common cause of hospital-acquired pneumonia with increasing antibiotic resistance
Advanced Detection Technology
Utilizing Real Time PCR methodology, this test amplifies and detects specific RNA sequences unique to each pathogen. The qualitative nature of the test provides definitive “detected” or “not detected” results for each organism, allowing for precise diagnosis and appropriate antimicrobial therapy selection.
Who Should Consider This Test
This comprehensive respiratory panel is recommended for individuals experiencing:
- Persistent cough lasting more than one week
- High fever with respiratory symptoms
- Difficulty breathing or shortness of breath
- Suspected pneumonia based on clinical presentation
- Recent exposure to confirmed cases of whooping cough or Legionnaires’ disease
- Hospital-acquired respiratory infections
- Immunocompromised patients with respiratory symptoms
- Patients not responding to initial antibiotic therapy
Clinical Indications
Healthcare providers typically order this test when patients present with symptoms suggestive of atypical pneumonia, when rapid pathogen identification is crucial for treatment decisions, or when conventional culture methods have failed to identify the causative organism.
Benefits of Bacterial Pneumonia Multiplex Testing
- Rapid Results: Receive comprehensive results within 36-48 hours, significantly faster than traditional culture methods
- Accurate Diagnosis: High specificity and sensitivity ensure reliable pathogen identification
- Targeted Treatment: Enables appropriate antibiotic selection based on identified pathogens
- Infection Control: Helps prevent disease transmission through early identification
- Reduced Hospital Stays: Timely diagnosis can lead to faster recovery and shorter hospitalization
- Cost-Effective: Comprehensive panel reduces the need for multiple individual tests
Understanding Your Test Results
Your test report will indicate whether each of the three pathogens was detected or not detected:
Positive Results
If any pathogen is detected, it indicates an active infection with that specific bacterium. Your healthcare provider will use this information to prescribe the most appropriate antibiotic therapy and implement necessary infection control measures.
Negative Results
A negative result for all three pathogens suggests that these specific bacteria are not causing your current respiratory symptoms. However, your physician may consider testing for other respiratory pathogens or investigating alternative causes for your symptoms.
Clinical Correlation
It’s important to remember that test results should always be interpreted in the context of your clinical symptoms, medical history, and physical examination findings by your healthcare provider.
Test Information and Pricing
| Test Component | Details |
|---|---|
| Test Name | Bacterial Pneumonia Multiplex Bordetella Legionella Klebsiella Detection Differentiation RNA Detection Qualitative Test |
| Regular Price | $426 USD |
| Discount Price | $298 USD |
| Turnaround Time | 4th Working Day Email: 48 hours | On Phone: 36 hours |
| Sample Types | Nasopharyngeal secretions, swabs, Oral/rectal swabs, necropsy samples, Blood, Urine, Sputum, throat swab, bronchoalveolar lavage samples, lung tissue |
| Testing Method | Real Time PCR |
Pre-Test Instructions
Before your test appointment, please ensure you:
- Sign the required Consent document
- Bring any relevant clinical history of the patient
- Follow any specific sample collection instructions provided by your healthcare provider
- Inform your physician about any current medications or treatments
Nationwide Testing Availability
GGC DNA has testing facilities conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.
Book Your Test Today
Don’t wait to get the answers you need for proper respiratory infection diagnosis and treatment. Our experienced genetic specialists are ready to assist you with comprehensive testing and clear result interpretation.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your Bacterial Pneumonia Multiplex Test or to speak with one of our genetic counseling specialists.
Take control of your respiratory health with accurate, timely pathogen detection from GGC DNA – your trusted partner in advanced molecular diagnostics.
